Learn Ins and Outs of Launching a Multicenter Clinical Trial

To help SVS members learn the necessary steps of setting up a multicenter clinical research study, this year’s Vascular Annual Meeting offers “The Nuts and Bolts of a Multicenter Clinical Trial.” The concurrent session will be held from 5 to…
VAM: Helping Patients with Vascular Disease

I always enjoy our Vascular Annual Meeting, and I look forward to it for months. It’s the leading forum for important and cutting-edge clinical and translational research, with presenters and attendees from across the country and around the world. Come…
VESS meeting and SAVS award

Winter VESS Meeting Highlights The annual winter meeting of the Vascular and Endovascular Surgery Society (VESS) provided an invaluable opportunity for students, trainees, and young vascular surgeons to exchange scientific data in a casual environment conducive to networking and career…
Mobile App: VAM Info at Your Fingertips

At the Vascular Annual Meeting, there’s no need to cart around a lot of paper. Instead, the Mobile App puts all the information you need – abstracts, exhibitor map, schedules and more – within fingertip reach, to keep you more…
Finding Food, Fun and History in DC Environs

National Harbor is a gateway port to Washington, D.C., situated just across the Potomac. For things to see and do while at the Vascular Annual Meeting, plan to vist the famous sights, monuments, museums, and cultural icons in the city…
Benvenuto, Bienvenue, Velkommen, Willkommen!

Welcome to the Capitol of the USA! More than 100 attendees at the 2016 Vascular Annual Meeting hail from overseas, coming to the nation’s capital from Argentina, China, Japan, the Netherlands, Poland, Sri Lanka, the Ukraine, the United Kingdom and…
Resident Research Prize: Seeking to Preserve AV Fistulae

Even though the use of arteriovenous fistulae (AVF) is considered optimal for hemodialysis access in patients with end-stage renal disease, outcomes for AVF are among the worst for any vascular procedure. Low rates of maturation result in up to 60%…
Presidential Address: ‘We Care!’

“Vascular surgeons are unique in the management of patients with circulatory disease. We are unique because we are exclusively devoted, 100% of our specialty, to the management of patients with vascular disease,” said Dr. Bruce A. Perler in his Presidential…
Dr. Gloviczki: Of Ties, VAM and a New Challenge

On Wednesday morning, the Society for Vascular Surgery bumped into SVS Past President Dr. Peter Gloviczki. Here’s what we learned about one of our leaders – who is stepping into a new role with the Society – and his participation…
We Must Lead on BEST-CLI Trial, Enroll Patients: Dr. Conte

Dr. Michael Conte issued an urgent call Thursday for vascular surgeons to enroll patients in the BEST-CLI Trial, designed to answer this question: What’s the best treatment for advanced critical limb ischemia? “This is a key opportunity to define optimal…

